Symbols

AIDX

20/20 Biolabs·NASDAQ

--(--)

AIDX Profile

20/20 Biolabs, Inc.

Industry

Healthcare Providers and Services

Established Date

08/07/2000

Listing Date

02/19/2026

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

2020biolabs.com

Security Type

Common stock

Office address

15810 Gaither Road Suite 235 Gaithersburg MD 20877

Business

Introduction

20/20 Biolabs, Inc., was incorporated in Delaware on August 7, 2000. The company develops and commercializes artificial intelligence-driven, lab-based blood tests focused on early detection and prevention of cancer and chronic diseases. The company offers two main families of laboratory tests under the OneTest brand: OneTest for Cancer, a multi-cancer early detection blood test, and OneTest for Longevity, which is expected to launch in the first half of 2026. Both tests are performed at the company's CAP-certified and CLIA-licensed laboratory in Gaithersburg, Maryland, which also houses a clinical laboratory innovation accelerator designed for diagnostic start-ups.